Jaguar Health (JAGX) Cash from Investing Activities Growth (1y) (2016 - 2025)
Jaguar Health (JAGX) Cash from Investing Activities Growth (1y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,774.59 Bn | 1,774.53 Bn | - | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 3 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn | 62.68% |
| 4 | Vertex Pharmaceuticals | 123.91 Bn | 116.66 Bn | 2.59 Bn | -674.01% |
| 5 | Regeneron Pharmaceuticals | 71.79 Bn | 63.04 Bn | 3.31 Bn | -166.24% |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - | - |
| 7 | Argenx Se | 54.75 Bn | 49.57 Bn | 1.41 Bn | - |
| 8 | Alnylam Pharmaceuticals | 38.10 Bn | 35.10 Bn | 959.66 Mn | -122.45% |
| 9 | Revolution Medicines | 36.11 Bn | 36.11 Bn | - | - |
| 10 | Jaguar Health | 509,443.80 | -9.55 Mn | 19.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 106.05% |
| Dec 31, 2022 | -103.45% |
| Sep 30, 2022 | 99.47% |
| Mar 31, 2018 | -101.33% |
| Dec 31, 2017 | -102.37% |
| Sep 30, 2017 | -1,473.61% |
| Jun 30, 2017 | -98.73% |
| Mar 31, 2017 | 426.89% |
| Dec 31, 2016 | -68.18% |